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Abstract 
Experimental  errors  in  the  genotyping  phases  of  a 
Genome-Wide Association Study (GWAS) can lead to 
false positive findings and to spurious associations. 
An appropriate quality control phase could minimize 
the  effects  of  this  kind  of  errors.  Several  filtering 
criteria  can  be  used  to  perform  quality  control. 
Currently, no formal methods have been proposed for 
taking into account at the same time these criteria 
and the experimenter’s preferences. In this paper we 
propose  two  strategies  for  setting  appropriate 
genotyping rate thresholds for GWAS quality control. 
These  two  approaches  are  based  on  the  Multi-
Criteria  Decision  Making  theory.  We  have  applied 
our  method  on  a  real  dataset  composed  by  734 
individuals  affected  by  Arterial  Hypertension  (AH) 
and 486 nonagenarians without history of AH. The 
proposed  strategies  appear  to  deal  with  GWAS 
quality  control  in  a  sound  way,  as  they  lead  to 
rationalize  and  make  explicit  the  experimenter’s 
choices thus providing more reproducible results.  
Introduction 
Data quality control is a crucial aspect of Genome-
Wide Association Studies (GWAS) analysis to avoid  
false  positives  and  to  properly  carry  on  data 
interpretation.  Experimental  systems  involving 
biological  material  are  typically  prone  to  errors:  if 
those  errors  would  be  randomly  distributed  across 
both genotypes and phenotypes, their effect would be 
limited to a loss of statistical power. However errors 
are  often  non-randomly  distributed.  This  lacks  of 
randomness  is  both  due  to  the  very  nature  of  the 
available  experimental  technologies  and  to  the 
presence of several concurrent factors such as: DNA 
quality  and  preparation,  specific  experimental 
conditions,  different  skills  of  the  experimenters, 
incorrect  automated  assignment  (or  “calling”)  of 
experimental intensity values into discrete genotype 
classes. Non random distribution of errors can inflate 
type I error rates and of course reduce the power of 
the  study.  Since  most  GWAS  aim  to  identify  very 
slight variations in allele frequencies between groups 
of individuals (cases and controls), even the presence 
of small experimental errors could dramatically affect 
the  outcome
1;2.  The  ideal  solution  to  this  kind  of 
problems  would  be  to  identify  individual  genotype 
errors  and  correct  them  one  at  a  time,  but  this  is 
almost impossible in GWAS. A feasible alternative is 
to  apply  filtering  procedures  in  order  to  identify 
specific SNPs yielding errors in multiple individuals 
(markers-affecting  errors),  or  individuals  in  the 
sample with errors across multiple SNPs (problems 
with  the  DNA  sample),  and  simply  exclude  them 
from  the  analysis.  Missing  individual  SNPs  or 
individual genotypes are frequent, but when missing 
rate exceeds 5% for SNPs or 10% for a  sample, there 
could be evidence of genotyping error, and a good 
choice would be to exclude that marker/DNA sample 
from the analysis and repeat the experiment
3. 
Several parameters can be used to evaluate the effect 
of the removal of SNPs and individuals on the quality 
of  the  association  study:  heterozygosity  rate,  SNPs 
deviations  from  the  Hardy  Weinberg  Equilibrium 
(HWE)  in  the  control  population  or  percentage  of 
markers  with  significant  difference  in  missing  data 
rates between cases and controls. Unfortunately, the 
setting  of  these  parameters  is  often  unclear  and 
subjective,  leading  to  a  lack  of  reproducibility  and 
false positive findings. It could be therefore useful to 
exploit more systematic approaches in order to help 
researchers in these crucial steps of the analysis.  
Currently, no formal methods have been proposed for 
choosing  the  most  appropriate  filtering  criteria  that 
take into account all of these factors. In this paper we 
propose to deal with this problem with a normative 
approach based on decision theory. We have applied 
two  different  Multi-Criteria  Decision  Making 
(MCDM)  methods  to the quality control steps of a 
GWAS for selecting the best filtering thresholds, in 
order to minimize the type I errors and maximize the 
statistical power related to the sample size. 
We  have  tested  our  method  on  a  real  dataset 
composed  by  1220  individuals  (734  cases,  486 
controls)  genotyped  using  Illumina  Infinium  II  and 
HumanHap  300  chips  [Illumina,  San  Diego,  CA, 
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USA] containing 318,237 PhaseII Hap map tagging 
SNPs [www.hapmap.org]. 
Methods: Parameters for quality control 
As described above, the main decisions that should be 
made by the data analyst for quality control in GWAS 
are the maximum number of missing genotyped SNPs 
per individual and the maximum number of missing 
individuals  per  SNPs.  Once  a  subset  of  SNPs  and 
individuals  are  selected,  different  parameters  are 
evaluated to check the quality of the available data. 
For  case-control  studies,  markers  with  significant 
difference  in  missing  data  rates  between  cases  and 
controls at a fixed significance threshold should be 
excluded  from  the  analysis  since  they  could  yield 
false  positive  associations
1.  Furthermore, SNPs that 
show  extremely  low  MAF  value  (<0.01),  could 
represent low genotyping-quality markers.  
Neutral  genetic  variants  in  a  large  random-mating 
population  are  expected  to  display  HWE,  under 
which  assumption  expected  genotype  frequencies 
satisfy E(MM)=p2, E(Mm)=2pq, E(mm)=q2, where p 
and q are the frequency of M and m alleles in the 
population, respectively. Genotyping errors can shift 
the  SNPs  observed  frequencies  from  the  expected 
proportions, and therefore testing for deviations from 
the  HWE  in  the  control  population  represents  a 
standard approach to detect genotyping errors
4. Such 
test can be performed using a Pearson goodness-of-fit 
statistic with one degree of freedom (d.f)
5, under the 
null hypothesis of HWE. Some problems are related 
to the application of this quality-filter: (1) biological 
factors  can  lead  SNPs  to  deviate  from  HWE 
potentially  related  to  true  causal  association,  which 
will  be  missed  if  the  marker  fails  the  test;  (2)  the 
significance threshold of the statistic is often unclear. 
Graphical displays such as plots and histograms could 
represent useful tools to assess the quality of the data 
and  to  identify  potential  low-quality  samples  and 
markers. One graphical inspection approach involves 
plotting the missing rate for each individual against 
the fraction of markers that are heterozygous 
3. This 
graphical  approach  can  highlight  low  quality/cross-
contaminated  DNA  samples  showing  extreme  
heterozygosity  rate  and  it  could  be  useful  for  the 
choice of an appropriate genotyping rate threshold. It 
could  be  also  useful  to  observe  the  relationship 
between missing rate statistic for each individual and 
the  genomic  inflation  factor  value  λ  (computed  by 
dividing the median of the test statistics by 0.456, the 
expected median of a χ2 distribution with 1 d.f.) 
6: an 
index of population stratification that could be also 
inflated by the presence of low-quality DNA samples. 
Methods: Multi-criteria decision making 
The choice of the best genotyping rate thresholds for 
individuals and SNPs can be considered as a MCDM 
problem
7,  that  implies  to  identify  and  choose 
alternatives  based  on the values and preferences of 
the decision maker. One paradigm of the MCDM is 
the  Multiple  Attribute  Decision  Making  (MADM) 
approach that requires that alternatives are described 
by a set of attributes or criteria (e.g. in our case the 
parameters described above).  
MADM  problems  are  assumed  to  have  a  finite 
number  of  alternatives  and  solving  the  problem 
means assigning a score to each alternative and then 
sorting  and  ranking  them.  Applications  of  MCDM 
require  that  preferences  associated  with  the 
alternatives are independent of each other from one 
criteria to another one. This means that the preference 
scores for all alternatives on a criteria are assigned 
with no knowledge about the alternatives preference 
scores on any of the other criteria. 
Once identified the criteria relevant for the problem, 
the next step is to rank the alternatives against each 
criteria  from  best  to  worst,  from  most  preferred  to 
least preferred: the decision maker is asked to assign 
a  score  measure  to  each  alternative  against  each 
criteria.  A  value  scale  from  0  to  100  can  be used, 
where the best preference is 100 and the worst is 0 
8. 
The assigned score measures are then represented in 
the evaluation matrix (S). Considering n alternatives 
and m criteria, S is a m X n matrix and the Sij element 
represents  the  score  of  alternative  Ai  according  to 
criteria  Cj.  We  assumed  that  a  higher  score  value 
means  a  better  performance  since  any  goal  of 
minimization  can  be  easily  transformed  into  a 
maximization  goal.  This  method  provides  the  basic 
framework  for  collecting  and  organizing  the 
information. In this case values are quantitative but 
MCDM  methods  allow  also  the  use  of  qualitative 
measures.  
Usually criteria are measured in different units, so the 
evaluation  matrix  has  to  be  normalized.  There  are 
different procedures for data standardization but the 
most frequently used are equations: 
1)  αij=Sij/max(Sij) 
2)  αij=(Sij-min(Sij))/(max(Sij)-min(Sij)) 
For all MCDM models is required that the choice of 
the best alternative is made taking into account the 
relative  importance  of  the  criteria,  so  a  weight  is 
assigned  to  each  criteria.  Criteria  weights  can  be 
assigned directly by the decision-maker or through a 
weighting methodology
9.  
75   
In our case a method based on the Analytic Hierarchy 
Process  (AHP)  seemed  the  most  appropriate.  The 
basic  idea  is  to  convert  subjective  assessments  of 
relative importance to a set of overall weights
10. The 
AHP  is  based  on  pairwise  comparisons  among 
criteria. For each pair of criteria, the decision maker 
is  required  to  answer  to  a  pairwise  comparison 
question asking the relative importance of the two. A 
nine-point scale can be used to express the intensity 
of the preference (1= Equal importance or preference; 
3=Moderate  importance  or  preference  of  one  over 
another;  5=Strong  or  essential  importance  or 
preference;  7=Very  strong  or  demonstrated 
importance or preference; 9=Extreme importance or 
preference).  If  it  is  judged  that  criteria  Ci  is  more 
important  of  criteria  Cj,  then  the  reciprocal  of  the 
relevant index is assigned (cij). The cij elements are 
represented into a comparison matrix C of size m X 
m.  
The matrix C is used to compute the weights for each 
criteria that are represented in the form of a vector 
w=(w1, w2, …, wm). There are different approaches to 
obtain it but the least squares method is simple and 
straightforward. This method consists of calculating 
the  geometric  mean  of  each  row  of  the  matrix  C, 
calculate  the  sum  of  the  geometric  means  and 
normalize each of the geometric means by dividing 
by the sum just computed
11. 
The  Simple  Multi-Attribute  Rating  Technique 
(SMART)  is  the  simplest  method  among  MADM. 
The ranking value xj of the alternative Aj is obtained 
by the following formula under an additive model: 
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The  best  alternative  is  the  one  with  the  highest 
ranking value. 
The  second  approach  we  have  tested  represents  an 
alternative  MCDM  strategy  that  implements  a 
different  procedure  for  criteria  weights  assignment, 
based on direct elicitation of user preferences.  
We  will  refer  to  this  method  as  D-MCDM. In this 
case the decision maker is not required to answer to a 
pairwise  comparison  question  about  the  relative 
importance between two criteria but he has to assign 
weights directly to each of them in a 0 to 10 scale. 
The  score  for  each  alternative  is  obtained  by  the 
following formula, where k represents the number of 
criteria  that  have  to  be  maximized  and  m-k  is  the 
number of criteria that should be minimized: 
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Results 
Our  medical  staff  recruited  734  patients  with  high 
blood pressure with age ranging between 35-55 years. 
The  control  population  is  represented  by  486 
nonagenarians collected during the course of the last 
few  years.  After  approval  of  the  ethical  committee 
and under informed consent collected following the 
Italian law, blood has been drawn from every patient 
participating  to  the  study.  DNA  has been extracted 
and  anamnestic,  clinical  and  laboratory  data  have 
been  collected.  All  samples  were  assayed  with  the 
Illumina  Infinium  II    and  HumanHap  300  chips 
containing 318,237 PhaseII Hap map tagging SNPs. 
Data  were  exported  by  Illumina  Bead  Studio 
Software with an average genotyping rate of 97%. 
Using gPLINK
12 we simulated to apply 10 different  
individual  missing  rate  filters:  from  10%  (remove 
individuals  with  genotyping  rate  <90%)  to  1% 
(remove individuals with genotyping rate <99%). For 
each  individual  missing/genotyping  filtering 
threshold,  we  applied  10  independent  SNP  missing 
rate/genotyping  rate  thresholds:  from  10%  (remove 
markers with genotyping rate <90%) to 1% (remove 
markers  with  genotyping  rate  <99%).  For  every 
combination  of  individual  and  SNP 
missing/genotyping rate filters we have computed the 
following parameters: 
•  percentage  of  individuals  (C1)  and  SNPs 
(C2) that pass the genotyping filters 
•  percentage  of  SNPs  excluded  because  of 
significant  difference  in  missing  data  rates 
between cases and controls (p<0.05) on the  
basis  on  the  Fisher  exact  test,  as 
implemented in gPLINK (C3) 
•  percentage of SNPs with MAF <1% (C4) 
•  percentage of SNPs deviating from the HWE 
in the control population (p<0.001) (Pearson 
goodness-of-fit statistic with one d.f.)
5. (C5) 
•  heterozygosity  rate  standard  deviation  per 
individual (C6) 
•  genomic  inflation  factor  (λ)  computed  by 
taking the median of the distribution of the 
chi-square  statistic  from  results  of  the 
Armitage Trend Test performed over the set 
of markers from the study, and dividing this 
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value  by  0.456,  the  median  of  the 
corresponding χ
2 distribution
6(C7). 
We applied the two MCDM methods considering a 
pair  of  individual  and  SNP  genotyping  rates  as  an 
alternative. The alternatives represent all the possible 
combinations of these two parameters (10x10). The 
parameters C1-C7 have been considered the criteria 
of  our  study.  Based  on  the  7  criteria  and  the  100 
alternatives, we built an evaluation matrix (S) of size 
7x100  (a  portion  of  the  evaluation  matrix  S  is 
represented in Table 1).  
In this work, the matrix S has been standardized using 
equation 1. Then we built the comparison matrix C 
(Table 2). Since the statistical power of a study relies 
on  the  number  of  analyzed  samples,  we  gave  high 
relative importance to this parameter, trying to keep 
the percentage of analyzed individuals high. In order 
to take into account in the study as many markers as 
possible,  we  maximized  a  second  parameter:  the 
percentage  of  SNPs  that  pass  the  genotyping filter. 
Otherwise  we  chose  to  minimize  the  values  of  the 
remaining criteria, since they may be index of low-
quality data. The matrix C has been used to compute 
the weights for each criteria as previously described. 
The obtained vector w is (0.33, 0.07, 0.07, 0.07, 0.07, 
0.33,  0.07).  By  applying  the  SMART  formula  we 
calculated  the  scores  corresponding  to  each 
alternative:  the  highest  score  corresponds  to  the 
alternative  “individual  genotyping  rate  >95%  and 
SNP genotyping rate >96%”, while the lowest score 
corresponds to the alternative “individual genotyping 
rate >90% and SNP genotyping rate >99%” (Figure 
1A).     
Then, we performed the same analysis using the D-
MCDM  approach,  setting  the  same  relative 
importance  assumptions  for  each  criteria  and 
performing  standardization  by  equation  2.  The 
highest score obtained corresponds to the alternative 
“individual  genotyping  rate  >95%  and  SNP 
genotyping  rate  >97%”,  while  the  lowest  score 
corresponds to the alternative “individual genotyping 
rate >90% and SNP genotyping rate >99%” (Figure 
1B). 
Finally,  in  order  to  perform  a  comparison  of  the 
results,  we  plotted  the  different  alternatives  against 
the  corresponding  normalized  scores  obtained  by 
applying the two previously described strategies for 
individual genotyping rate 95% and 99% (Figure 2). 
 
 
Alternatives 
Criteria 
CR90,SNP90  CR90,SNP91  … 
C1  100  99  … 
C2  7  7  … 
C3  96  96  … 
C4  35  40  … 
C5  90  90  … 
C6  100  100  … 
C7  53  53  … 
Table 1. Evaluation matrix S 
  C1  C2  C3  C4  C5  C6  C7 
C1  1  5  5  5  5  1  5 
C2  1/5  1  1  1  1  1/5  1 
C3  1/5  1  1  1  1  1/5  1 
C4  1/5  1  1  1  1  1/5  1 
C5  1/5  1  1  1  1  1/5  1 
C6  1  5  5  5  5  1  5 
C7  1/5  1  1  1  1  1/5  1 
Table 2. Comparison matrix C 
A   B  
Figure  1.  SMART  (A)  and  D-MCDM  (B)  score 
profiles  (“CR”  and  “SNP”  indicate  individual  and 
SNP genotyping rate, respectively) 
Discussion 
The results we obtained by using the two strategies 
are  very  similar  for  individual  genotyping  rates 
<95%, with comparable score profiles. For individual 
genotyping rates >96% the interpretation of the two 
profiles is more complex: the profiles derived from 
the D-MCDM seem to decrease more rapidly than the 
ones generated by the SMART approach. D-MCMD 
penalizes  more  extreme  choices,  in  particular  high 
values  of  the  genotyping  rates:  by  applying  very 
stringent  samples  genotyping  filters  we risk to lose 
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useful data, with a decrease of the sample size and, 
therefore, statistical power (Figure 1). This result is 
due to the elicitation process of the criteria weights, 
which  is  done  independently  for  each  criteria.  The 
process  may  lead  to  sharper  shapes  of  the  score 
function. On the contrary, SMART is able to take into 
account correlations between criteria and therefore is 
related to smoother score functions (Figure 2).  
Figure 2. SMART and D-MCDM score profiles for 
individual genotyping rate 95% (A) and 99% (B) 
However, SMART is a more “expensive” model in 
terms  of  time  required  for  the  elicitation  process, 
since it requires pairwise comparison for the relative 
weights assignment. D-MCDM, instead, only requires 
to give a weight to each criteria, which can be easily 
obtained by a direct score elicitation strategy,  such as 
ranking–based ones
 9. 
Conclusions 
The  strategies  presented  in  this  paper  can  be 
considered as instruments to perform a quality control 
dealing  with  GWAS.  In  particular  they  lead  to  set 
appropriate  thresholds,  rationalizing  and  making 
explicit  the  experimenter’s  choices  with  the  aim  to 
provide more reproducible results. As shown in this 
paper, the experimenter is asked to provide a vector 
(D-MCDM) or a matrix of  weights (SMART); then, 
after computing the evaluation matrix S, the method 
provides a principled way to take decisions and an 
instrument  to  understand  if  decisions  may  change 
when case different weighting strategies are chosen. 
Finally,  our  methodology  can  be  easily  applied  to 
other datasets where researchers can define their own 
criteria  and  weights.  By  making  them  explicit,  the 
results  obtained  can  be  fully  reproducible  by  other 
research groups, even starting from the row data. 
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